Lawrence Clifford McDonald1. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Abstract
BACKGROUND: Antibiotics have profound and lasting effects on the lower intestinal (gut) microbiome that can both promote resistance and increase susceptibility to colonization and infection; knowledge of these changes is important to the prevention and treatment of traveler's diarrhea. METHODS: Recent data from epidemiologic and modern metagenomics studies were reviewed in regard to how such findings could inform the prevention and treatment of traveler's diarrhea. RESULTS: Although it is well recognized that antibiotics increase the risk for Clostridium difficile infection, it is less recognized how they predispose patients to typically foodborne pathogens such as Salmonella or Camplyobacter spp. While these pathogens account for only a fraction of traveler's diarrhea, such predisposition reflects how antibiotic exposure that precedes or occurs during travel may increase the risk for infection with other more common pathogens, even possibly enterotoxigenic Eschericia coli, especially in the setting of acquired resistance. Even short antibiotic exposures disrupt the gut microbiome up to a year or more and repeated exposures appear to attenuate recovery from ever occurring. One bacterial phylum that commonly increases in the gut following antibiotics are the proteobacteria including Enterobacteriacea; these are pro-inflammatory and often carry antibiotic resistance genes, the number and diversity of these genes (i.e. the resistome) commonly expands following antibiotics. The gut resistome among healthy community-dwelling adults reflects geographic variability in antibiotic use practices in both humans and food-producing animals as well as possibly the transmission of antibiotic resistance genes through the food supply. CONCLUSIONS: Because antibiotic use among travelers will influence the resistome and thereby promote geographic spread of resistance, it is important that antibiotic use recommendations for travelers be guided by resistance surveillance data as well as a careful assessment of the risks and benefits to both the individual and society. Published by Oxford University Press 2016. This work is written by a US Government employee and is in the public domain in the US.
BACKGROUND: Antibiotics have profound and lasting effects on the lower intestinal (gut) microbiome that can both promote resistance and increase susceptibility to colonization and infection; knowledge of these changes is important to the prevention and treatment of traveler's diarrhea. METHODS: Recent data from epidemiologic and modern metagenomics studies were reviewed in regard to how such findings could inform the prevention and treatment of traveler's diarrhea. RESULTS: Although it is well recognized that antibiotics increase the risk for Clostridium difficileinfection, it is less recognized how they predispose patients to typically foodborne pathogens such as Salmonella or Camplyobacter spp. While these pathogens account for only a fraction of traveler's diarrhea, such predisposition reflects how antibiotic exposure that precedes or occurs during travel may increase the risk for infection with other more common pathogens, even possibly enterotoxigenic Eschericia coli, especially in the setting of acquired resistance. Even short antibiotic exposures disrupt the gut microbiome up to a year or more and repeated exposures appear to attenuate recovery from ever occurring. One bacterial phylum that commonly increases in the gut following antibiotics are the proteobacteria including Enterobacteriacea; these are pro-inflammatory and often carry antibiotic resistance genes, the number and diversity of these genes (i.e. the resistome) commonly expands following antibiotics. The gut resistome among healthy community-dwelling adults reflects geographic variability in antibiotic use practices in both humans and food-producing animals as well as possibly the transmission of antibiotic resistance genes through the food supply. CONCLUSIONS: Because antibiotic use among travelers will influence the resistome and thereby promote geographic spread of resistance, it is important that antibiotic use recommendations for travelers be guided by resistance surveillance data as well as a careful assessment of the risks and benefits to both the individual and society. Published by Oxford University Press 2016. This work is written by a US Government employee and is in the public domain in the US.
Authors: Emily E Ricotta; Amanda Palmer; Katie Wymore; Paula Clogher; Nadine Oosmanally; Trisha Robinson; Sarah Lathrop; Jillian Karr; Julie Hatch; John Dunn; Patricia Ryan; David Blythe Journal: Am J Public Health Date: 2014-05-15 Impact factor: 9.308
Authors: Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork Journal: Nature Date: 2011-04-20 Impact factor: 49.962
Authors: Lapo Mughini-Gras; Remko Enserink; Ingrid Friesema; Max Heck; Yvonne van Duynhoven; Wilfrid van Pelt Journal: PLoS One Date: 2014-02-04 Impact factor: 3.240
Authors: Melissa B Miller; Faranak Atrzadeh; C A Burnham; Stephen Cavalieri; James Dunn; Stephen Jones; Charles Mathews; Peggy McNult; John Meduri; Chris Newhouse; Duane Newton; Michael Oberholzer; John Osiecki; David Pedersen; Nicole Sweeney; Natalie Whitfield; Joe Campos Journal: J Clin Microbiol Date: 2019-08-26 Impact factor: 5.948
Authors: Jennifer L Cannon; Matthew H Seabolt; Ruijie Xu; Anna Montmayeur; Soo Hwan Suh; Marta Diez-Valcarce; Filemón Bucardo; Sylvia Becker-Dreps; Jan Vinjé Journal: Viruses Date: 2022-06-27 Impact factor: 5.818
Authors: Esabelle Lo Yan Yam; Li Yang Hsu; Eric Peng-Huat Yap; Tsin Wen Yeo; Vernon Lee; Joergen Schlundt; May O Lwin; Direk Limmathurotsakul; Mark Jit; Peter Dedon; Paul Turner; Annelies Wilder-Smith Journal: Antimicrob Resist Infect Control Date: 2019-12-18 Impact factor: 4.887
Authors: Karen T Elvers; Victoria J Wilson; Ashley Hammond; Lorna Duncan; Alyson L Huntley; Alastair D Hay; Esther T van der Werf Journal: BMJ Open Date: 2020-09-21 Impact factor: 2.692